Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	28.79	11.29	14.69	9.6	34.89	32.67
Short-Term Investments	115.98	140.23	24.79	31.82	-	-
Cash & Short-Term Investments	144.78	151.52	39.49	41.42	34.89	32.67
Cash Growth	262.69%	283.70%	-4.67%	18.74%	6.79%	230.45%
Receivables	0.06	10.37	10.37	0.55	0.39	0.06
Prepaid Expenses	1.41	1.5	1	0.92	1.16	0.96
Total Current Assets	146.25	163.39	50.86	42.89	36.44	33.68
Property, Plant & Equipment	7.26	6.87	7.61	6.94	4.62	0.85
Other Intangible Assets	-	-	-	-	-	0
Other Long-Term Assets	0.25	0.22	0.27	0.27	0.28	0.09
Total Assets	153.77	170.48	58.73	50.09	41.33	34.62
Accounts Payable	5.25	8.18	6.24	4.83	3.12	2.72
Accrued Expenses	4.24	0.01	0.01	0.09	0.6	0.01
Current Portion of Long-Term Debt	-	-	-	-	-	0.25
Current Portion of Leases	0.84	0.83	0.75	0.68	0.42	-
Current Unearned Revenue	12	12	24.27	17.98	-	-
Total Current Liabilities	22.34	21.03	31.27	23.59	4.13	2.97
Long-Term Debt	-	-	-	-	-	0.07
Long-Term Leases	0.41	0.62	1.49	1.88	2.45	-
Long-Term Unearned Revenue	-	-	-	9.47	-	-
Other Long-Term Liabilities	3.38	3.38	3.38	3.38	3.38	3.38
Total Liabilities	26.12	25.02	36.13	38.31	9.96	6.42
Common Stock	0.05	0.05	0.03	0.03	0.02	0.02
Additional Paid-In Capital	350.01	344.22	181.7	148.74	139.4	116.22
Retained Earnings	-224.23	-199.83	-159.37	-137.08	-108.06	-88.04
Comprehensive Income & Other	1.81	1.03	0.24	0.11	-	-
Shareholders' Equity	127.65	145.46	22.6	11.79	31.37	28.2
Total Liabilities & Equity	153.77	170.48	58.73	50.09	41.33	34.62
Total Debt	1.25	1.45	2.24	2.56	2.87	0.32
Net Cash (Debt)	143.53	150.06	37.25	38.86	32.01	32.35
Net Cash Growth	278.74%	302.84%	-4.14%	21.38%	-1.03%	227.23%
Net Cash Per Share	3.70	4.26	1.39	1.58	1.39	2.08
Filing Date Shares Outstanding	45.71	45.68	31.4	25.26	24.3	22.8
Total Common Shares Outstanding	45.68	45.58	31.15	25.24	24.19	20.58
Working Capital	123.91	142.36	19.59	19.3	32.3	30.71
Book Value Per Share	2.79	3.19	0.73	0.47	1.30	1.37
Tangible Book Value	127.65	145.46	22.6	11.79	31.37	28.2
Tangible Book Value Per Share	2.79	3.19	0.73	0.47	1.30	1.37
Machinery	7.17	6.51	5.64	4.38	0.04	1.52
Leasehold Improvements	2.64	2.5	2.13	1.39	2.51	0.05

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q